Which Factors Will Push The Transfection Technologies Market To Achieve $1.83 Billion By 2029?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Projected Valuation Of The Transfection Technologies Market In The Coming Years?
In recent years, the market size of transfection technologies has experienced significant growth. It is predicted to increase from $1.21 billion in 2024 to $1.31 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. The past growth in this sector is largely due to the rising occurrence of chronic diseases, the broadening utilization of transfection technologies, the escalating demand for cell and gene therapy, higher investments in research and development, and the increasing rates of cancer incidents.
In the ensuing years, a robust expansion is anticipated in the transfection technologies market, with projections reaching $1.83 billion by 2029 at a CAGR of 8.8%. This predicted growth within the forecasted period can be ascribed to a variety of factors. Included amongst these are an escalating prevalence of chronic and immunological diseases, the growing necessity for therapies based on cell manipulation, an increase in protein production demand, a surge in investments and funding for drug delivery system development, plus a heightened demand for monoclonal antibodies. The forecast period is also expected to witness major trends such as a surge in research and development focused on cell-based therapies, the acceptance of cutting-edge methods in transfection, rising demand for advanced therapeutic delivery systems, an increased application of dual-reporter assays and co-transfection experiments along with a growing emphasis on personalized medicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
What Are The Primary Factors Supporting The Transfection Technologies Market Expansion?
The growth of the transfection technologies market is anticipated to be fueled by the in gene therapy. Gene therapy is an approach that seeks to prevent or treat diseases by altering genes, which involves the insertion, repair, or replacement of defective genes. The increased trajectory of gene therapy is influenced by advancements in genetic research, improved delivery techniques, and its capacity to manage previously untreatable genetic conditions. Transfection technologies have a pivotal role in gene therapy as they enable the accurate, safe, and efficient transport of genetic material into cells. These technologies help with both temporary and permanent modifications of the genome, which are critical for the treatment of genetic disorders and cancers. As an illustration, the American Society of Gene & Cell Therapy (ASGCT) and Citeline, both US-based entities, reported in July 2023 that there were 247 gene therapies in Phase II at the end of the first quarter (Q1) of 2023. This figure rose by 5%, reaching 260 by the close of the second quarter (Q2). As such, the growth of the transfection technologies market is being spurred on by the increase in gene therapy.
What Is The Segment Breakdown Of The Transfection Technologies Market?
The transfection technologies market covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
How Are Global Trends Impacting The Development Of The Transfection Technologies Market?
Key players in the transfection technologies industry are concentrating their efforts on creating innovative technology like mechanoporation transfection systems. These systems are designed to support intricate and bespoke applications in research and treatment fields. The technique behind mechanoporation transfection systems involves using mechanical force to open temporary pores in cell membranes, providing a passageway for genetic material into cells. This technique is more efficient and less invasive, maintaining higher cell survival rates. For example, in July 2024, STEMCELL Technologies, a Canadian biotech firm, introduced CellPore, a groundbreaking transfection system. The system comprises of a benchtop device along with the CellPore Transfection Kit 300, equipped with a unique reagent kit and one-time use delivery cartridges. CellPore uses a controlled, rapid deformation process in microfluidic channels to effectively insert small molecules, nucleic acids, proteins, and gene editing complexes into cells. This ensures minimal cell disruption and high cell viability. Such attributes are vital in pushing research boundaries and creating new cell and gene therapies.
Which Companies Are Contributing Significantly To The Transfection Technologies Market Growth?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report
Which Region Is Leading Innovation In The Transfection Technologies Market?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
